438 related articles for article (PubMed ID: 27288651)
21. BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo.
Ren Y; Huang SH; Patel S; Alberto WDC; Magat D; Ahimovic D; Macedo AB; Durga R; Chan D; Zale E; Mota TM; Truong R; Rohwetter T; McCann CD; Kovacs CM; Benko E; Wimpelberg A; Cannon C; Hardy WD; Bosque A; Bollard CM; Jones RB
J Clin Invest; 2020 May; 130(5):2542-2559. PubMed ID: 32027622
[TBL] [Abstract][Full Text] [Related]
22. DC-based immunotherapy as strategy to purge the HIV reservoir?
Søgaard OS
EBioMedicine; 2019 May; 43():16-17. PubMed ID: 30981650
[No Abstract] [Full Text] [Related]
23. Maintenance of CD4+ T-cell memory and HIV persistence: keeping memory, keeping HIV.
Chomont N; DaFonseca S; Vandergeeten C; Ancuta P; Sékaly RP
Curr Opin HIV AIDS; 2011 Jan; 6(1):30-6. PubMed ID: 21242891
[TBL] [Abstract][Full Text] [Related]
24. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.
Redel L; Le Douce V; Cherrier T; Marban C; Janossy A; Aunis D; Van Lint C; Rohr O; Schwartz C
J Leukoc Biol; 2010 Apr; 87(4):575-88. PubMed ID: 19801499
[TBL] [Abstract][Full Text] [Related]
26. Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1.
Siliciano JD; Siliciano RF
J Allergy Clin Immunol; 2014 Jul; 134(1):12-9. PubMed ID: 25117799
[TBL] [Abstract][Full Text] [Related]
27. Development of CAR-T cells for long-term eradication and surveillance of HIV-1 reservoir.
Liu B; Zhang W; Zhang H
Curr Opin Virol; 2019 Oct; 38():21-30. PubMed ID: 31132749
[TBL] [Abstract][Full Text] [Related]
28. Experimental approaches to the study of HIV-1 latency.
Han Y; Wind-Rotolo M; Yang HC; Siliciano JD; Siliciano RF
Nat Rev Microbiol; 2007 Feb; 5(2):95-106. PubMed ID: 17224919
[TBL] [Abstract][Full Text] [Related]
29. Towards an HIV-1 cure: measuring the latent reservoir.
Bruner KM; Hosmane NN; Siliciano RF
Trends Microbiol; 2015 Apr; 23(4):192-203. PubMed ID: 25747663
[TBL] [Abstract][Full Text] [Related]
30. Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients.
Petitjean G; Al Tabaa Y; Tuaillon E; Mettling C; Baillat V; Reynes J; Segondy M; Vendrell JP
Retrovirology; 2007 Aug; 4():60. PubMed ID: 17727722
[TBL] [Abstract][Full Text] [Related]
31. Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenance.
Olivetta E; Chiozzini C; Arenaccio C; Manfredi F; Ferrantelli F; Federico M
Cytokine Growth Factor Rev; 2020 Feb; 51():40-48. PubMed ID: 31926807
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of HIV-1 latent reservoirs.
Zhao JC; Deng K
Chin Med J (Engl); 2020 Dec; 133(23):2867-2873. PubMed ID: 33273337
[TBL] [Abstract][Full Text] [Related]
33. HIV persistence: silence or resistance?
Pasternak AO; Berkhout B
Curr Opin Virol; 2023 Apr; 59():101301. PubMed ID: 36805974
[TBL] [Abstract][Full Text] [Related]
34. Immuno-modulatory strategies for reduction of HIV reservoir cells.
Banks HT; Flores KB; Hu S; Rosenberg E; Buzon M; Yu X; Lichterfeld M
J Theor Biol; 2015 May; 372():146-58. PubMed ID: 25701451
[TBL] [Abstract][Full Text] [Related]
35. Differences in inducibility of the latent HIV reservoir in perinatal and adult infection.
Dhummakupt A; Rubens JH; Anderson T; Powell L; Nonyane BA; Siems LV; Collinson-Streng A; Nilles T; Jones RB; Tepper V; Agwu A; Persaud D
JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31999647
[TBL] [Abstract][Full Text] [Related]
36. Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.
Sung JA; Pickeral J; Liu L; Stanfield-Oakley SA; Lam CY; Garrido C; Pollara J; LaBranche C; Bonsignori M; Moody MA; Yang Y; Parks R; Archin N; Allard B; Kirchherr J; Kuruc JD; Gay CL; Cohen MS; Ochsenbauer C; Soderberg K; Liao HX; Montefiori D; Moore P; Johnson S; Koenig S; Haynes BF; Nordstrom JL; Margolis DM; Ferrari G
J Clin Invest; 2015 Nov; 125(11):4077-90. PubMed ID: 26413868
[TBL] [Abstract][Full Text] [Related]
37. The Impact of Cellular Proliferation on the HIV-1 Reservoir.
Virgilio MC; Collins KL
Viruses; 2020 Jan; 12(2):. PubMed ID: 31973022
[TBL] [Abstract][Full Text] [Related]
38. Multifarious immunotherapeutic approaches to cure HIV-1 infection.
Imami N; Herasimtschuk AA
Hum Vaccin Immunother; 2015; 11(9):2287-93. PubMed ID: 26048144
[TBL] [Abstract][Full Text] [Related]
39. Are T cells the only HIV-1 reservoir?
Kandathil AJ; Sugawara S; Balagopal A
Retrovirology; 2016 Dec; 13(1):86. PubMed ID: 27998285
[TBL] [Abstract][Full Text] [Related]
40. Developing strategies for HIV-1 eradication.
Durand CM; Blankson JN; Siliciano RF
Trends Immunol; 2012 Nov; 33(11):554-62. PubMed ID: 22867874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
